Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stark Investments was a global multi-strategy alternative investment firm founded in 1992 by Brian Stark and Michael Roth. Headquartered in St. Francis, Wisconsin, the firm managed a diverse range of assets, including significant investments in the healthcare and biotechnology sectors during its peak. At its height, Stark Investments was one of the largest hedge funds in the world, known for its expertise in convertible arbitrage and distressed debt. However, following the 2008 financial crisis and subsequent investor redemptions, the firm began winding down its operations and returned the majority of its managed capital to investors by 2013.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stark Investments.